GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mapk3 | increases activity | EXP | | 6480464 | CTD | Losartan results in increased activity of MAPK3 protein | PMID:11711055 | Mapk3 | increases phosphorylation | EXP | | 6480464 | CTD | Losartan results in increased phosphorylation of MAPK3 protein | PMID:20056918 | Mapk3 | multiple interactions | EXP | | 6480464 | CTD | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Losartan results in increased phosphorylation of MAPK3 protein]; [Losartan co-treated with Vitamin D] inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK3 protein]; Losartan inhibits the reaction [[AGT protein binds to and results in increased localization of AGTR1A protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Losartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; Losartan inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK3 protein] | PMID:18267125 PMID:18511912 PMID:20056918 PMID:34590760 | Mapk3 | multiple interactions | ISO | MAPK3 (Homo sapiens) | 6480464 | CTD | Losartan inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein] | PMID:16079071 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |